Rohto Optic Glow
NDC 10742-8160, Naphazoline hydrochloride, Povidone, Propylene glycol, liquid, from The Mentholatum Company.
- Product NDC
- 10742-8160
- Status
- Listed
- Labeler
- The Mentholatum Company
- Dosage form
- LIQUID
- Route
- OPHTHALMIC
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M018
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10742-8160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPHAZOLINE HYDROCHLORIDE.3 mg/mL
- POVIDONE, UNSPECIFIED5 mg/mL
- PROPYLENE GLYCOL2 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10742-8160-1 | 10742816001 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (10742-8160-1) / 13 mL in 1 BOTTLE, WITH APPLICATOR |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 10742-8160 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10742-8160 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10742-8160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.